GMDA News and Press, Gamida Cell Ltd. From 10/09/20

Welcome to Seeking Alpha's Catalyst Watch - a breakdown of some of next week's actionable events that stand out. Check out Saturday morning's regular Stocks to Watch article for a full list of events planned for the week or the Seeking Alpha earnings calendar for companies due to report. Mond...

Gamida Cell Ltd. (Nasdaq: GMDA), an advanced cell therapy company committed to finding cures for blood cancers and serious blood diseases, today announced that Michele Korfin, chief operating and chief commercial officer, will present at the annual Cell & Gene Meeting on the Mesa to...

Westwater Resources (WWR) +53%.Xtant Medical Holdings (XTNT) +29% after regaining compliance with NYSE's continued listing standards.Alteryx (AYX) +25% on raising Q3 revenue guidance.CBAK Energy Technology (CBAT) +22%.Ocean Power Technologies (OPTT) +20%.Oxbridge Re Holdin...

Gamida Cell (GMDA) jumps 15% premarket after announcing that the Phase 3 study of omidubicel, an investigational advanced cell therapy in development for patients in need of bone marrow transplant, met all three of its secondary endpoints. The Phase 3 study was designed to evaluate ...

— Study met secondary endpoints related to platelet engraftment, infections and hospitalizations, key clinical measures in bone marrow transplant — — Omidubicel represents potential transformative treatment option for patients in need of a bone marrow tran...

— Study shows younger donor age is associated with improved outcomes following bone marrow transplant — Gamida Cell Ltd. (Nasdaq: GMDA), an advanced cell therapy company committed to cures for blood cancers and serious blood diseases, today announced data from an observ...

Gamida Cell Ltd. (Nasdaq: GMDA), an advanced cell therapy company committed to finding cures for blood cancers and serious blood diseases, today announced that company management will participate in three upcoming virtual investor conferences in September: H.C. Wainwright 22 nd Annual G...

Gamida Cell Ltd. (Nasdaq: GMDA), an advanced cell therapy company committed to cures for blood cancers and serious blood diseases, today announced that it will host a two-part virtual miniseries in September focused on key topics related to omidubicel , an advanced cell therapy in Phase 3 ...

Gamida Cell Ltd. (Nasdaq: GMDA), an advanced cell therapy company committed to cures for blood cancers and serious blood diseases, today announced that it will webcast its Annual Meeting of Stockholders on Thursday, September 10, 2020, at 10:00 a.m. ET (5:00 p.m. Israel time) at 12 Leshem Str...

Gamida Cell Ltd (GMDA) Q2 2020 Earnings Conference Call Aug 11, 2020 8:30 AM ET Company Participants Jaren Madden - Vice President, Investor Relations and Corporate Communications Julian Adams - Chief Executive Officer Ronit Simantov - Chief Medical Officer Shai Lankry - Chief...